Cowen and Company’s Revelation Biosciences Warrant REVBW Stock Holding History

Cowen and Company’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-99,900	Closed	-$1.5K	–	245
2024 Q3	$1.5K	Sell	99,900 -100	-0.1%	-$1	﹤0.01%	588
2024 Q2	$2K	Buy	100,000 +100	+0.1%	+$2	﹤0.01%	572
2024 Q1	$2.65K	Sell	99,900 -200	-0.2%	-$3	﹤0.01%	618
2023 Q4	$1.06K	Hold	100,100	–	–	﹤0.01%	556
2023 Q3	$1.69K	Buy	100,100 +1,804	+2%	+$30	﹤0.01%	601
2023 Q2	$1.75K	Hold	98,296	–	–	﹤0.01%	547
2023 Q1	$1.59K	Buy	+98,296	New	+$2.47K	﹤0.01%	536

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

PVI

Pine Valley Investments Marlton, New Jersey $2.53B AUM 36.18% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cowen and Company's REVBW Position: Q4 2024 in Review

Cowen and Company sold out of Revelation Biosciences Warrant (REVBW) in Q4 2024, closing a stake of 99,900 shares — an estimated $1.5K sold.

Cowen and Company first reported a position in REVBW in Q1 2023 and held it in 7 quarters. The position peaked at $2.65K in Q1 2024. 11 funds tracked by Wall St. Rank hold REVBW as of Q4 2024.

Cowen and Company reported no remaining Revelation Biosciences Warrant position as of Q4 2024 after selling out during the quarter.
Cowen and Company sold 99,900 Revelation Biosciences Warrant shares in Q4 2024, an estimated $1.5K.
Cowen and Company first reported a position in Revelation Biosciences Warrant in Q1 2023 and held it in 7 quarters.
Cowen and Company's Revelation Biosciences Warrant position peaked at $2.65K in Q1 2024.
11 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.